Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Irene Perlich Insider Profile
4 Followers
Irene Perlich, CAO at NGM Biopharmaceuticals, holds 0.00 shares in NGM Biopharmaceuticals (Ticker: NGM).
Irene Perlich NGM Biopharmaceuticals (NGM)CAO
NGM Biopharmaceuticals (NGM)
CAO
Not Ranked
Irene Perlich has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Irene Perlich does not currently own shares as a corporate insider.
A breakdown of Irene Perlich's holdings
Insider Roles
Irene Perlich does not currently hold a role as a corporate insider.
Roles that Irene Perlich holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Irene Perlich
Irene Perlich's Trading History
List of latest transactions for each holding click on a transaction to see Irene Perlich's performance on stock
You May Also Like
Irene Perlich insider profile FAQ
What is the percentage of profitable transactions made by Irene Perlich?
The percentage of profitable transactions made by Irene Perlich is ―.
What is the average return per transaction made by Irene Perlich?
The average return per transaction made by Irene Perlich is ―.
What stocks does Irene Perlich hold?
Irene Perlich holds: NGM stocks.
What was Irene Perlich’s latest transaction?
Irene Perlich latest transaction was an Uninformative Sell of ―.
What was Irene Perlich's most profitable transaction?
Irene Perlich’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Irene Perlich's role in NGM Biopharmaceuticals?
Irene Perlich's role in NGM Biopharmaceuticals is CAO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.